| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.57B | 23.96B | 25.75B | 31.96B | 30.86B | 23.71B |
| Gross Profit | 4.86B | 5.27B | 3.56B | 9.65B | 9.14B | 5.67B |
| EBITDA | 1.62B | 1.84B | 571.96M | 5.62B | 5.21B | 2.42B |
| Net Income | -2.41B | -2.36B | -4.30B | 2.18B | 3.16B | 933.59M |
Balance Sheet | ||||||
| Total Assets | 33.51B | 33.61B | 36.64B | 37.05B | 34.77B | 31.51B |
| Cash, Cash Equivalents and Short-Term Investments | 9.52B | 9.43B | 9.23B | 8.57B | 10.22B | 11.74B |
| Total Debt | 13.50B | 12.98B | 11.52B | 7.88B | 5.84B | 7.39B |
| Total Liabilities | 16.54B | 16.21B | 16.08B | 12.45B | 12.04B | 11.72B |
| Stockholders Equity | 16.97B | 17.40B | 20.55B | 24.59B | 22.73B | 19.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -521.13M | -2.31B | -3.19B | 139.43M | 548.78M |
| Operating Cash Flow | 0.00 | 3.36B | 1.93B | 1.29B | 1.75B | 1.79B |
| Investing Cash Flow | 0.00 | -3.76B | -4.55B | -4.57B | -1.61B | -1.55B |
| Financing Cash Flow | 0.00 | 442.36M | 2.71B | 1.51B | -2.06B | 2.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥142.35B | 2.91 | 1.86% | 0.76% | -16.19% | -50.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥4.72T | -74.70 | -2.51% | 1.31% | -10.97% | -118.87% | |
56 Neutral | ¥10.13B | 10.86 | ― | 1.86% | -7.54% | ― | |
55 Neutral | ¥175.68B | -13.62 | ― | ― | -51.82% | -96.08% | |
52 Neutral | ¥1.46T | 47.56 | -4.26% | 2.30% | 0.04% | -323.26% | |
45 Neutral | ¥19.60B | 15.70 | ― | 3.98% | -6.84% | 50.71% |